”A European patent granted for Medicortex” – published 11.12.2025.
”Medicortex Signs a Share Purchase Agreement (SPA) with Nosium Ab (publ) – Strengthens Path Toward Commercializing TBI Diagnostics” – published 24.11.2025.
”A patent granted for Medicortex” – published 28.8.2025.
”Medicortex Finland Plc signed a 1.4 million dollars research grant contract with the U.S. Department of Defense” – published 24.6.2024.
”Medicortex Finland Plc appointing new members for the Board of Directors” – published 3.5.2024.
”Extension to Business Finland funding decision” – published 27.2.2024.
”Medicortex was granted a European patent for detection of biomarker indicative to brain injury” – published 24.1.2024.
”Business Finland supporting Medicortex” – published 15.1.2024.
”Medicortex was granted a Finnish patent related to the detection of tissue damage” – published 28.8.2023.
”Medicortexin syksyn 2023 rahoituskierros käynnistynyt – sijoittajille tiedossa bonus” – published 18.8.2023.
”Medicortex Finland was granted a European patent related to the diagnostics of COVID-19 in saliva” – published 12.7.2023.
”Turun kaupunki myönsi Medicortexille TKI-setelin” – published 15.6.2023.
”Medicortex concluding the fundraising round of spring 2023 – company grateful for the public interest” – published 30.5.2023.
”New Shareholders for Medicortex” – published 3.3.2023.
”Medicortex Finland Plc appointing a new advisor” – published 1.12.2022.
”Medicortex Finland Plc signed a 2 million dollars research grant contract with the US Department of Defense” – published 25.10.2022.